Literature DB >> 18663314

A homozygous L299P mutation in the CYP11B1 gene leads to complete virilization in 46,XX individuals with 11-beta-hydroxylase deficiency.

Stefan Riedl1, Huy-Hoang Nguyen, Susanne Clausmeyer, Egbert Schulze, Franz Waldhauser, Rita Bernhardt.   

Abstract

BACKGROUND/AIM: 11-beta-hydroxylase deficiency (11betaOHD) is caused by CYP11B1 gene defects and leads to congenital adrenal hyperplasia associated with hypertension. Recently, a novel L299P mutation has been described in a compound heterozygous male individual. We observed two 46,XX siblings with a homozygous L299P mutation and investigated the functional properties of this CYP11B1 variant. PATIENTS: The index patient from a consanguineous Turkish family showed complete external virilization and was diagnosed incidentally at the age of 19 months during hospital admission for severe combined bacterial (urosepsis) and viral (CMV and EBV) infection. The younger sibling was diagnosed at the age of 5 months. Their genital phenotype was identical and both demonstrated borderline elevated blood pressure.
RESULTS: Biochemical findings revealed 11betaOHD. A homozygous L299P mutation of the CYP11B1 gene was detected. In vitro expression studies performed in HCT116 cells showed a markedly decreased CYP11B1 activity in the L299P mutant (1.6 +/- 0.8%) for the conversion of 11-deoxycortisol to cortisol.
CONCLUSIONS: Our study provides clear data on the functional properties and clinical phenotype in 46,XX individuals homozygous for this point mutation. Adrenal insufficiency might have contributed to the severe infectious disease that was present in the index patient at diagnosis. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663314     DOI: 10.1159/000137659

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  4 in total

Review 1.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

2.  Clinical and Genetic Characteristics of Patients with Common and Rare Types of Congenital Adrenal Hyperplasia: Novel Variants in STAR and CYP17A1.

Authors:  Ozge Koprulu; Behzat Ozkan; Sezer Acar; Ozlem Nalbantoglu; Beyhan Ozkaya Donmez; Gulcin Arslan; Filiz Hazan; Semra Gursoy
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-06-28

3.  Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency.

Authors:  Silvia Parajes; Lourdes Loidi; Nicole Reisch; Vivek Dhir; Ian T Rose; Rainer Hampel; Marcus Quinkler; Gerard S Conway; Lidia Castro-Feijóo; David Araujo-Vilar; Manuel Pombo; Fernando Dominguez; Emma L Williams; Trevor R Cole; Jeremy M Kirk; Elke Kaminsky; Gill Rumsby; Wiebke Arlt; Nils Krone
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

Review 4.  Non-classical 11β-hydroxylase deficiency caused by compound heterozygous mutations: a case study and literature review.

Authors:  Dongdong Wang; Jiahui Wang; Tong Tong; Qing Yang
Journal:  J Ovarian Res       Date:  2018-09-17       Impact factor: 4.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.